Frazier Life Sciences Management, L.P. Oric Pharmaceuticals, Inc. Transaction History
Frazier Life Sciences Management, L.P.
- $1.67 Billion
- Q4 2024
A detailed history of Frazier Life Sciences Management, L.P. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 3,888,238 shares of ORIC stock, worth $29 Million. This represents 1.88% of its overall portfolio holdings.
Number of Shares
3,888,238
Previous 4,142,855
6.15%
Holding current value
$29 Million
Previous $42.5 Million
26.11%
% of portfolio
1.88%
Previous 2.29%
Shares
3 transactions
Others Institutions Holding ORIC
# of Institutions
132Shares Held
67.3MCall Options Held
404KPut Options Held
6.4K-
Nextech Invest Ag5.29MShares$39.5 Million7.95% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$36.1 Million0.0% of portfolio
-
Viking Global Investors LP4.43MShares$33.1 Million0.12% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$32.8 Million5.85% of portfolio
-
Alkeon Capital Management LLC New York, NY3.9MShares$29.2 Million0.07% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $296M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...